
    
      30 Patients were enrolled to the study, either to the hyperoncotic HES 200/0.5 (10%) group or
      to the crystalloids only group. After a treatment protocol of 72 hours we collected data
      about complications like pulmonary failure and abdominal compartment syndrome. Furthermore,
      we addressed the question of incidence of mortality and renal failure.
    
  